Stay updated on Trametinib and Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trametinib and Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trametinib and Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer’s site revision changes from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T11:49:38.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and says that, under Executive Order 14434, NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.
    Difference
    1%
    Check dated 2026-10-26T11:16:39.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2; the displayed 403 error page remains otherwise unchanged.
    Difference
    0.2%
    Check dated 2026-10-19T11:59:26.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T14:19:32.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, replacing the previously visible trial information with an access-restricted error screen. This change indicates the trial record is currently unavailable due to an access issue.
    Difference
    19%
    Check dated 2026-09-21T20:28:34.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6. This indicates a newer version of the page has been published, with no visible changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-31T17:49:14.000Z thumbnail image

Stay in the know with updates to Trametinib and Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trametinib and Pembrolizumab in NSCLC Clinical Trial page.